168 related articles for article (PubMed ID: 11518466)
1. Low pO2 and beta-estradiol induce VEGF in MCF-7 and MCF-7-5C cells: relationship to in vivo hypoxia.
Maity A; Sall W; Koch CJ; Oprysko PR; Evans SM
Breast Cancer Res Treat; 2001 May; 67(1):51-60. PubMed ID: 11518466
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
[TBL] [Abstract][Full Text] [Related]
3. In vitro regulation of vascular endothelial growth factor by estrogens and antiestrogens in estrogen-receptor positive breast cancer.
Takei H; Lee ES; Jordan VC
Breast Cancer; 2002; 9(1):39-42. PubMed ID: 12196720
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo.
Marxsen JH; Schmitt O; Metzen E; Jelkmann W; Hellwig-Bürgel T
Ann Anat; 2001 May; 183(3):243-9. PubMed ID: 11396794
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia.
Bausero P; Ben-Mahdi M; Mazucatelli J; Bloy C; Perrot-Applanat M
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2033-42. PubMed ID: 11045935
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen induces hypoxia in MCF-7 xenografts.
Evans SM; Koch CJ; Laughlin KM; Jenkins WT; Van Winkle T; Wilson DF
Cancer Res; 1997 Nov; 57(22):5155-61. PubMed ID: 9371518
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo.
Guo P; Fang Q; Tao HQ; Schafer CA; Fenton BM; Ding I; Hu B; Cheng SY
Cancer Res; 2003 Aug; 63(15):4684-91. PubMed ID: 12907650
[TBL] [Abstract][Full Text] [Related]
9. Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor.
McLeskey SW; Tobias CA; Vezza PR; Filie AC; Kern FG; Hanfelt J
Am J Pathol; 1998 Dec; 153(6):1993-2006. PubMed ID: 9846989
[TBL] [Abstract][Full Text] [Related]
10. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y
Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia and VEGF mRNA expression in human tumors.
Ziemer LS; Koch CJ; Maity A; Magarelli DP; Horan AM; Evans SM
Neoplasia; 2001; 3(6):500-8. PubMed ID: 11774032
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia reduces hormone responsiveness of human breast cancer cells.
Kurebayashi J; Otsuki T; Moriya T; Sonoo H
Jpn J Cancer Res; 2001 Oct; 92(10):1093-101. PubMed ID: 11676860
[TBL] [Abstract][Full Text] [Related]
16. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
Osipo C; Meeke K; Cheng D; Weichel A; Bertucci A; Liu H; Jordan VC
Int J Oncol; 2007 Feb; 30(2):509-20. PubMed ID: 17203234
[TBL] [Abstract][Full Text] [Related]
17. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP.
Miyamoto N; Mandai M; Takagi H; Suzuma I; Suzuma K; Koyama S; Otani A; Oh H; Honda Y
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2007-14. PubMed ID: 12037012
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens.
Coradini D; Pellizzaro C; Speranza A; Daidone MG
Cell Mol Life Sci; 2004 Jan; 61(1):76-82. PubMed ID: 14704855
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo.
Garvin S; Dabrosin C
Cancer Res; 2003 Dec; 63(24):8742-8. PubMed ID: 14695189
[TBL] [Abstract][Full Text] [Related]
20. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
